Clinical Trial Update: Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate [Phase 1]

View source ↗

Summary

Phase 1 single-blind cross-over dose-response study comparing two inhalers containing salmeterol and fluticasone propionate in healthy subjects; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• Salmeterol (salmeterol)
• fluticasone propionate inhaler (fluticasone propionate)

Snippet

Sponsor: Kindeva Drug Delivery | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2020-11-02